Videos and Podcasts

31st Aug 21

Pharmaxis Hails Positive Results in Phase 1 Scarring Trial

Pharmaxis CEO Gary Phillips speaks to Proactive Investors following the news its novel topical drug treatment for scarring has delivered positive phase 1 clinical trial results and will now advance to the next stage of development in patients with established scars.

Watch the interview here.